| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| RNU4ATAC |
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
|
0.556 |
0.808 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| TMX2-CTNND1 |
|
TMX2-CTNND1 readthrough (NMD candidate)
|
|
|
0.538 |
0.769 |
| WHCR |
|
Wolf-Hirschhorn syndrome chromosome region
|
|
|
0.638 |
0.577 |
| H19-ICR |
|
H19/IGF2 imprinting control region
|
|
|
0.631 |
0.615 |
| MRD2 |
|
Mental retardation, autosomal dominant 2
|
|
|
1.000 |
0.038 |
| SH3PXD2B |
A1X283
|
SH3 and PX domains 2B
|
|
4.2E-03 |
0.631 |
0.577 |
| NBAS |
A2RRP1
|
NBAS subunit of NRZ tethering complex
|
|
5.0E-43 |
0.566 |
0.692 |
| NKX2-6 |
A6NCS4
|
NK2 homeobox 6
|
Transcription factor
|
1.9E-02 |
0.695 |
0.385 |
| A2ML1 |
A8K2U0
|
alpha-2-macroglobulin like 1
|
Enzyme modulator
|
1.6E-34 |
0.590 |
0.692 |
| DVL1 |
O14640
|
dishevelled segment polarity protein 1
|
Signaling
|
3.7E-06 |
0.531 |
0.769 |
| MRAS |
O14807
|
muscle RAS oncogene homolog
|
Enzyme modulator
|
0.92 |
0.590 |
0.731 |
| CPLX1 |
O14810
|
complexin 1
|
|
0.82 |
0.576 |
0.654 |
| MUSK |
O15146
|
muscle associated receptor tyrosine kinase
|
Kinase
|
4.2E-08 |
0.570 |
0.769 |
| FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
| FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
| PHGDH |
O43175
|
phosphoglycerate dehydrogenase
|
Enzyme
|
1.3E-04 |
0.484 |
0.885 |
| TBX1 |
O43435
|
T-box transcription factor 1
|
Transcription factor
|
0.84 |
0.433 |
0.808 |
| RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
| XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
| CTNND1 |
O60716
|
catenin delta 1
|
Cellular structure
|
1.00 |
0.500 |
0.808 |
| LRP4 |
O75096
|
LDL receptor related protein 4
|
|
1.4E-06 |
0.568 |
0.692 |
| FLNB |
O75369
|
filamin B
|
|
6.1E-10 |
0.458 |
0.923 |
| CDC45 |
O75419
|
cell division cycle 45
|
Nucleic acid binding
|
4.6E-05 |
0.588 |
0.692 |